TAMARIS COTTA: Open Payments
NPI 1003253881 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 17 payments from 9 companies in 2025. Trend: 2023 $741 · 2024 $579 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Hologic Sales and Service, LLC | 2 | $135 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $108 |
| Octapharma USA, Inc. | 2 | $45 |
| Sage Therapeutics, LLC | 3 | $43 |
| Astellas Pharma US Inc | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| MILLICENT US INC | 1 | $22 |
| Exeltis, USA Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: NOVASURE, FIBRYGA, ZURZUVAE, Veozah, Lynkuet, FEMLYV, SLYND, APTIMA.
Industry payments across NV — which companies pay providers there.
